Jacopo Farina

Jacopo Farina


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2026 in JACC: Advances
Verified
Journal Article
Open access
SBSimone Biscaglia
Simone Biscaglia
DTDaniela Trabattoni
Daniela Trabattoni
PCPaolo Canova
Paolo Canova
ABAlberto Boi
Alberto Boi
FBFrancesco Bruno
Francesco Bruno
RVRocco Vergallo
Rocco Vergallo
Intracoronary imaging improves outcomes in complex percutaneous coronary intervention (PCI), yet its implementation in routine practice remains inconsistent. This study sought to quantify the implementation gap for intracoronary imaging in contemporary PCI, identify operator-reported barriers to its use when predefined guideline-based anatomic criteria were present, and characterize modality selection beyond those criteria. OCT2ACT was a prospective, multicenter study enrolling 1,189 consecutive patients across 23 Italian imaging-capable centers between September 15 and December 15, 2025. Patients were classified as follows: cohort 1, predefined class IA anatomic criteria with no imaging; cohort 2, predefined class IA anatomic criteria with imaging; and cohort 3, imaging use outside these criteria. Among 908 patients meeting predefined class IA criteria, 481 (53.0%) did not undergo intracoronary imaging. The most frequent barriers were operator-reported attitudinal factors, with angiography considered sufficient or imaging judged unlikely to change PCI strategy in 278 patients (57.8%). Imaging uptake varied substantially across centers (16.7% to 100.0%). In cohort 2, IVUS was the predominant modality (72%), whereas in cohort 3 optical coherence tomography was more common (54%), mainly for diagnostic clarification in ambiguous acute coronary syndromes or stent failure. Even in imaging-capable centers, intracoronary imaging remains underused in anatomically complex PCI. This implementation gap appears driven predominantly by operator attitudes and intersite practice variation rather than by cost or technical barriers alone. (Barriers Limiting OCT Penetration in Clinical Practice [OCT2ACT]; NCT07193693).

17 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JFJacopo Farina
Jacopo Farina
Mauro BiffiMauro Biffi
Mauro Biffi
GFGianluca Folesani
Gianluca Folesani
LMLuca Di Marco
Luca Di Marco
SMSofia Martin
Sofia Martin
DPDavide Pacini
Davide Pacini
Background: Bradyarrhythmia requiring pacemaker implantation among patients undergoing valve surgery may occur even after several years, with unclear predictors. Our aim was to investigate the incidence of pacemaker implantation at different follow-up times and identify associated predictors. Methods: We conducted a retrospective study evaluating 1046 consecutive patients who underwent valve surgery at the Cardiac Surgery Division of Bologna University Hospital from 2005 to 2010. Results: During 10 ± 4 years of follow-up, 11.4% of these patients required pacemaker implantation. Interventions on both atrioventricular valves independently predicted long-term pacemaker implantation (SHR 2.1, 95% CI 1.2–3.8, p = 0.014). Preoperative atrioventricular conduction disease strongly predicted long-term atrioventricular block, with right bundle branch block as the major predictor (SHR 7.0, 95% CI 3.9–12.4, p < 0.001), followed by left bundle branch block (SHR 4.9, 95% CI 2.4–10.1, p < 0.001), and left anterior fascicular block (SHR 3.9, 95% CI 1.8–8.3, p < 0.001). Conclusion: Patients undergoing valvular surgery have a continuing risk of atrioventricular block late after surgery until the 12-month follow-up, which was clearly superior to the rate of atrioventricular block observed at long-term. Pre-operative atrioventricular conduction disease and combined surgery on both atrioventricular valves are strong predictors of atrioventricular block requiring pacemaker implantation.

1 November 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
ASAlberto Sarti
Alberto Sarti
AEAndrea Erriquez
Andrea Erriquez
BPBeatrice Dal Passo
Beatrice Dal Passo
GCGianni Casella
Gianni Casella
VGVincenzo Guiducci
Vincenzo Guiducci
SBSimone Biscaglia
Simone Biscaglia
BACKGROUND: The FIRE trial (Functional Assessment in Elderly Myocardial Infarction Patients With Multivessel Disease) showed the superiority of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease. Whether this result applies equally to patients at higher risk of ischemic events due to nonculprit lesion complexity is unclear. METHODS: Overall, 1445 patients were randomized to culprit-only or complete revascularization. In this prespecified analysis, patients were divided into those with or without at least 1 complex nonculprit lesion. A nonculprit lesion was defined as complex if it met any of the following criteria: angiographic heavy calcification, ostial lesion, true bifurcation lesion involving side-branches >2.5 mm, in-stent restenosis, or long-lesions (estimated stent length >28 mm). The primary outcome comprised a composite of death, MI, stroke, or revascularization at 3 years. The key secondary outcome was a composite of cardiovascular death or MI. The safety outcome included a composite of contrast-associated acute kidney injury, stroke, and Bleeding Academic Research Consortium 3 to 5. RESULTS: Overall, 641 patients (44%, complex subgroup) had at least 1 complex nonculprit lesion, whereas 804 patients (56%, noncomplex subgroup) did not. After adjustment for potential confounders, patients in the complex subgroup were at higher risk of 3-year cardiovascular death or MI (hazard risk [HR], 1.32 [95% CI, 1.01–1.74]), MI (HR, 2.33 [95% CI, 1.44–3.78]) and ischemia-driven coronary revascularization (HR, 2.28 [95% CI, 1.46–3.56]). Complete revascularization reduced the primary outcome in both the complex (HR, 0.75 [95% CI, 0.56–0.99]) and noncomplex (HR, 0.71 [95% CI, 0.53–0.95]) subgroups, with no significant interaction ( P for interaction=0.625). Similarly, no evidence of heterogeneity related to nonculprit lesion complexity was observed for either key secondary or safety end points. CONCLUSIONS: In older patients with MI and multivessel disease, physiology-guided complete revascularization reduced ischemic events, regardless of the complexity of nonculprit lesions. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03772743.

27 July 2026 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
SCSerena Caglioni
Serena Caglioni
ARAndrea Raisi
Andrea Raisi
AEAndrea Erriquez
Andrea Erriquez
TPTommaso Piva
Tommaso Piva
MCMarta Cocco
Marta Cocco
Gianluca CampoGianluca Campo
Gianluca Campo

9 October 2025 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
PRPruthvi C. Revaiah
Pruthvi C. Revaiah
TTTsung‐Ying Tsai
Tsung‐Ying Tsai
JFJacopo Farina
Jacopo Farina
GFGonçalo Ferraz-Costa
Gonçalo Ferraz-Costa
JJJochem Jongenotter
Jochem Jongenotter
PSPatrick Serruys
Patrick Serruys

28 June 2024 in Journal of Cardiovascular Medicine
Verified
Journal Article
Closed access
JFJacopo Farina
Jacopo Farina
SBSimone Biscaglia
Simone Biscaglia
GCGianluca Campo
Gianluca Campo
FPFederico Pappalardo
Federico Pappalardo